NEW YORK, Dec. 14, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
In 2010, the Asia Pacific markets for cardiac rhythm management (CRM), electrophysiology and ablation devices were valued at over $1.4 billion. This market covers:
- Implantable Cardioverter-Defibrillators (ICDs),
- Cardiac Resynchronization Therapy devices (CRTs),
- Cardiac stimulation leads,
- External defibrillators,
- Ablation catheters, and
- Diagnostic electrophysiology (EP) catheters
The countries covered in this report include Japan, South Korea and Australia.
Although the markets declined slightly in 2010, they are expected to reach $2 billion by 2017.
Within the cardiac rhythm management (CRM), electrophysiology and ablation device report, companies such as Boston Scientific, Cardiac Science, Medtronic, Sorin Group and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available for purchase.
Copyright©2010 PR Newswire.
All rights reserved